Zidovudine, lamivudine and dolutegravir (AXD) Relative to Tenofovir, lamivudine and dolutegravir (TXD) In Second Line Antiretroviral Therapy (ARTIST) Trial: a randomised controlled trial

Principal investigator

Petros Isaakidis
Purpose of study
Purpose of study

As the HIV epidemic matures and more patients are initiated on antiretroviral treatment, focus is on ensuring that those on antiretroviral therapy are virologically suppressed. The strategy to support virological suppression on second-line include...

Study status

  • Concept
  • Protocol & ERB
  • Implementation
  • Completion
  • Archived

Study timeline


  • AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial
    Zhao, Ying "–" F1000 Research Ltd "(2021)"
Previous study
Next study